Philadelphia-based Thomas Jefferson University, owner of Jefferson Health, recorded an operating loss of $29.3 million (-0.3% operating margin) through the first three quarters of fiscal 2025, compared to an operating loss of $30.2 million (-0.4% margin) during the same period last year, according to its May 15 financial report.
Four things to know:
1. Jefferson’s total operating revenue and expenses through the nine months ended March 31 were each about $4 billion higher than the same period last year, primarily due to its Aug. 1 merger with Allentown, Pa.-based Lehigh Valley Health.
2. Jefferson’s operating revenue through the third quarter of 2025 was $11.3 billion, 5.7% above budget expectations. Net patient service revenue was 3.3% above budget, insurance premium revenue was 6.4% above, and other revenue was 45.4% above, driven mainly by higher ambulatory pharmacy revenue.
3. Operating expenses totaled $11.4 billion through the first three quarters of the fiscal year, 6.2% above budget expectations. The overage was driven by supply costs (12.4% above budget), drugs (24.9% above) and insurance services medical expenses (22.2% above).
4. Jefferson had 117.3 days cash on hand as of March 31, down from 140.4 on June 30.
